Covid-19 News

COVID-19

• Communicable disease threats report, 30 May - 5 June 2026, Week 23 June 5, 2026
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on SARS-CoV-2 variant classification, Ebola, Middle East respiratory syndrome (MERS), mpox, West Nile virus, Salmonella, Dermatophilus congolensis and malaria.
• Communicable disease threats report, 23-29 May 2026, Week 22 May 29, 2026
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on Ebola, hantavirus, cholera, and West Nile virus.
• ECDC hosts annual meeting of the European Respiratory Viruses Network May 27, 2026
  The European Centre for Disease Prevention and Control (ECDC) hosted the annual meeting of the European Respiratory Viruses Network (ERVI-Net) in Vienna, Austria, on 20–22 May 2026, which brought together nearly 80 representatives from EU/EEA and accession countries.
• Communicable disease threats report, 14-22 May 2026, Week 21 May 22, 2026
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-22 May 2026, and includes updates on hantavirus, chikungunya, Ebola disease outbreak, avian influenza, measles, and an overview of respiratory virus epidemiology in the EU/EEA.
• Weekly respiratory virus update, week 20, May 2026 May 22, 2026
  Respiratory virus activity remains low overall across the EU/EEA: RSV: activity has returned to baseline inter-seasonal levels. Influenza: activity remains at baseline inter-seasonal levels. SARS-CoV-2: activity remains at very low levels overall.
• Standard laboratory protocols for SARS-CoV-2 characterisation May 19, 2026
  This handbook provides an updated overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2, provided by the AURORAE consortium.
• Communicable disease threats report, 2-8 May 2026, Week 19 May 8, 2026
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 May 2026, and includes updates on hantavirus, mpox, Middle East respiratory syndrome coronavirus (MERS-CoV), Salmonella Stanley, and an overview of respiratory virus epidemiology in the EU/EEA.
• Weekly respiratory virus update, week 18, May 2026 May 8, 2026
  Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity; still the main contributor to severe disease, with the seasonal peak largely passed. Influenza: activity has returned to inter-seasonal levels. SARS-CoV-2: Very low activity overall, despite early signs of sustained transmission in primary care.
• The European Respiratory Virus Surveillance Summary (ERVISS) May 8, 2026
  This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
• Weekly respiratory virus update, week 17, April 2026 May 4, 2026
  Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity and returning to baseline levels, with the seasonal peak already passed in most countries. Influenza: activity has returned to inter-seasonal levels. COVID 19: Very low activity.